World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
60
Citations
13011
World Ranking
3123
National Ranking
179

Philippe Halfon publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Philippe Halfon sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 288 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Philippe Halfon D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe Halfon sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 60 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Philippe Halfon is affiliated with Université Paris Cité in France and has contributed extensively to research in medicine and biochemistry, genetics, and molecular biology.

Their primary fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these main disciplines, subfields of study are centered on:

  • Infectious Diseases
  • Epidemiology
  • Molecular Biology
  • Hepatology
  • Neurology

Major research topics covered by Halfon include:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Autophagy in Disease and Therapy
  • Long-Term Effects of COVID-19
  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Gut microbiota and health

Halfon's publication record involves various journals and repositories, with frequent publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • PLoS ONE
  • Research Square (Research Square)
  • Viruses

Some recent papers authored or co-authored by Halfon include:

  • "Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis" (2021, The Journal of Infectious Diseases)
  • "A Granulocytic Signature Identifies COVID-19 and Its Severity" (2020, The Journal of Infectious Diseases)
  • "GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions" (2021, Autophagy)
  • "Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis" (2020, bioRxiv [Cold Spring Harbor Laboratory])
  • "Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery" (2022, Frontiers in Immunology)

The scientist has frequently collaborated with a group of co-authors including:

  • Soraya Mezouar
  • Guillaume Pénaranda
  • Eloïne Bestion
  • Anne Plauzolles
  • Jean-Louis Mège

Best Publications

  • Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

    J. Durant;P. Clevenbergh;P. Halfon;P. Delgiudice

  • Meta-analyses of FibroTest diagnostic value in chronic liver disease

    Thierry Poynard;Rachel Morra;Philippe Halfon;Laurent Castera

  • Hepatitis C virus resistance to protease inhibitors.

    Philippe Halfon;Stephen Locarnini

  • CpG methylation controls reactivation of HIV from latency.

    Jana Blazkova;Katerina Trejbalova;Katerina Trejbalova;Françoise Gondois-Rey;Philippe Halfon

  • CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

    Vivien Béziat;Vivien Béziat;Vivien Béziat;Olav Dalgard;Tarik Asselah;Philippe Halfon

  • HCV direct‐acting antiviral agents: the best interferon‐free combinations

    Raymond Schinazi;Philippe Halfon;Patrick Marcellin;Tarik Asselah

  • Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.

    J Durant;P Clevenbergh;R Garraffo;P Halfon

  • Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

    Thierry Poynard;Philippe Halfon;Laurent Castera;Mona Munteanu

  • SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C

    Giada Sebastiani;Philippe Halfon;Laurent Castera;Stanislas Pol

  • Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus.

    Philippe Halfon;Marc Bourlière;Guillaume Pénaranda;Romaric Deydier

  • Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study

    Philippe Halfon;Marc Bourliere;Romaric Deydier;Danielle Botta-Fridlund

  • Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients

    Caroline Solas;Alain Lafeuillade;Philippe Halfon;Stéphane Chadapaud

  • Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

    Etienne Patin;Etienne Patin;Zoltán Kutalik;Zoltán Kutalik;Julien Guergnon;Stéphanie Bibert

  • Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations.

    Jérôme Deval;Kirsten L. White;Michael D. Miller;Neil T. Parkin

  • Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study

    Giada Sebastiani;Diego Tempesta;Giovanna Fattovich;Laurent Castera

  • Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.

    Asma Boumaza;Soraya Mezouar;Eloïne Bestion

  • Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA

    Philippe Halfon;Hacène Khiri;Victoria Gérolami;Marc Bourlière

  • Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study

    Joseph Monsonego;Michael G. Hudgens;Laurent Zerat;Jean Claude Zerat

  • Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

    C. Payan;F. Roudot-Thoraval;P. Marcellin;N. Bled

  • How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited.

    Jerome Lambert;Philippe Halfon;Guillaume Penaranda;Pierre Bedossa

  • Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C

    Philippe Halfon;Yannick Bacq;Anne De Muret;Guillaume Penaranda

  • Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.

    Jérôme Boursier;Yannick Bacq;Philippe Halfon;Vincent Leroy

Frequent Co-Authors

Marc Bourlière
Marc Bourlière Hôpital Saint Joseph
Patrice Cacoub
Patrice Cacoub Sorbonne University
Stanislas Pol
Stanislas Pol Université Paris Cité
Albert Tran
Albert Tran Inserm : Institut national de la santé et de la recherche médicale
Thierry Poynard
Thierry Poynard Sorbonne University
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Fabrice Carrat
Fabrice Carrat Sorbonne University
Daniel Olive
Daniel Olive Aix-Marseille University
Philippe Colson
Philippe Colson Aix-Marseille University
Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring fast online medical billing and coding certification programs can provide a complementary skill set in healthcare administration. These certifications often require less time and offer a quicker entry into the medical field.

Additionally, some aspiring healthcare professionals wonder what medical degree can i get online. While opportunities for fully online medical degrees are limited, there are related health science courses and hybrid programs that support microbiology students seeking broader medical knowledge.

For those drawn to public health, investigating easy admission online MPH programs offers a way to gain public health expertise quickly. This pathway aligns well with microbiology careers focused on epidemiology and disease prevention.

Finally, the healthcare sector values roles like child life specialists. Knowing how much does a child life specialist make can guide students considering this rewarding human-centered career path.

By understanding these related degrees and career options, microbiology students in the USA can tailor their education to fit diverse and evolving healthcare roles.

Best Scientists Citing Philippe Halfon

Trending Scientists

Recently Published Articles